These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24171482)

  • 1. In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker.
    Ababneh N; Alshaer W; Allozi O; Mahafzah A; El-Khateeb M; Hillaireau H; Noiray M; Fattal E; Ismail S
    Nucleic Acid Ther; 2013 Dec; 23(6):401-7. PubMed ID: 24171482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
    Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
    Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer.
    Kim YJ; Lee HS; Jung DE; Kim JM; Song SY
    J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27891685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
    Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
    Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44.
    Somasunderam A; Thiviyanathan V; Tanaka T; Li X; Neerathilingam M; Lokesh GL; Mann A; Peng Y; Ferrari M; Klostergaard J; Gorenstein DG
    Biochemistry; 2010 Oct; 49(42):9106-12. PubMed ID: 20843027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.
    Iida J; Clancy R; Dorchak J; Somiari RI; Somiari S; Cutler ML; Mural RJ; Shriver CD
    PLoS One; 2014; 9(2):e88712. PubMed ID: 24586375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2.
    Chen F; Hu Y; Li D; Chen H; Zhang XL
    PLoS One; 2009 Dec; 4(12):e8142. PubMed ID: 19997645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.
    Sett A; Borthakur BB; Bora U
    Clin Transl Oncol; 2017 Aug; 19(8):976-988. PubMed ID: 28224267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of DNA aptamers using Cell-SELEX.
    Sefah K; Shangguan D; Xiong X; O'Donoghue MB; Tan W
    Nat Protoc; 2010 Jun; 5(6):1169-85. PubMed ID: 20539292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of aptamers specific to colorectal cancer cells and stem cells by utilizing On-chip Cell-SELEX.
    Hung LY; Wang CH; Che YJ; Fu CY; Chang HY; Wang K; Lee GB
    Sci Rep; 2015 May; 5():10326. PubMed ID: 25999049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capture and detection of Staphylococcus aureus with dual labeled aptamers to cell surface components.
    Ramlal S; Mondal B; Lavu PS; N B; Kingston J
    Int J Food Microbiol; 2018 Jan; 265():74-83. PubMed ID: 29132030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of an aptamer against mouse GP2 by SELEX.
    Hanazato M; Nakato G; Nishikawa F; Hase K; Nishikawa S; Ohno H
    Cell Struct Funct; 2014; 39(1):23-9. PubMed ID: 24334484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of DNA aptamers against glioblastoma cells with high affinity and specificity.
    Kang D; Wang J; Zhang W; Song Y; Li X; Zou Y; Zhu M; Zhu Z; Chen F; Yang CJ
    PLoS One; 2012; 7(10):e42731. PubMed ID: 23056171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma.
    Lo CW; Chan CKW; Yu J; He M; Choi CHJ; Lau JYW; Wong N
    Nanotheranostics; 2022; 6(2):161-174. PubMed ID: 34976591
    [No Abstract]   [Full Text] [Related]  

  • 17. Selection of DNA aptamers recognizing small cell lung cancer using living cell-SELEX.
    Kunii T; Ogura S; Mie M; Kobatake E
    Analyst; 2011 Apr; 136(7):1310-2. PubMed ID: 21321690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.
    Shangguan D; Cao ZC; Li Y; Tan W
    Clin Chem; 2007 Jun; 53(6):1153-5. PubMed ID: 17463173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display.
    Park HY; Lee KJ; Lee SJ; Yoon MY
    Mol Biotechnol; 2012 Jul; 51(3):212-20. PubMed ID: 21979823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.